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Abstract
Renal vascular responses to pregnancy have frequently been studied, by investigating renal vascular resistance (RVR), renal
flow, glomerular filtration rate (GFR), and renal artery responses to stimuli. Nonetheless, several questions remain: 1. Which
vasodilator pathways are activated and to what extent do they affect RVR, renal flow and GFR across species, strains and
gestational ages, 2. Are these changes dependent on renal artery adaptation, 3. At which cellular level does pregnancy
affect the involved pathways? In an attempt to answer the questions raised, we performed a systematic review and meta-
analysis on animal data. We included 37 studies (116 responses). At mid-gestation, RVR and GFR change to a similar degree
across species and strains, accompanied by variable change in renal flow. At least in rats, changes depend on NO activation.
At late gestation, changes in RVR, renal flow and GFR vary between species and strains. In rats, these changes are
effectuated by sympathetic stimulation. Overall, renal artery responsiveness to stimuli is unaffected by pregnancy, except
for Sprague Dawley rats in which pregnancy enhances renal artery vascular compliance and reduces renal artery myogenic
reactivity. Our meta-analysis shows that: 1. Pregnancy changes RVR, renal flow and GFR dependent on NO-activation and
sympathetic de-activation, but adjustments are different among species, strains and gestational ages; 2. These changes do
not depend on adaptation of renal artery responsiveness; 3. It remains unknown at which cellular level pregnancy affects
the pathways. Our meta-analysis suggests that renal changes during pregnancy in animals are qualitatively similar, even in
comparison to humans, but quantitatively different.
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Introduction
Profound vasodilation takes place in early pregnancy, and
results in a major reduction in systemic vascular resistance.
Vasodilation seems to be maximal at mid-gestation and slowly
decreases towards term pregnancy in both humans [1] and
animals [2]. Several local vascular responses, affecting the
endothelial cell (EC), smooth muscle cell (SMC) and extracellular
matrix, are thought to be responsible for gestational vasodilation
by: 1. Up regulation of the endothelium-dependent nitric oxide
(NO) pathway [3], 2. Reduction of the responsiveness to
vasoconstrictor stimuli [4], 3. Reduction in myogenic reactivity
[5], and 4. Increase in arterial compliance [5]. It remains to be
determined to what extent each factor contributes to gestational
vasodilation at the various stages of pregnancy among different
species and strains.
Many studies on the mechanisms of vasodilation in pregnancy
have focused on the kidney and its renal arteries. The kidney is a
prominent vascular region and major contributor to systemic
vascular resistance in the non-pregnant and pregnant condition
[6,7]. Vessel tone has been studied by investigating several local
vascular responses. These responses can be divided by the stimulus
involved: 1. Mechanical stimuli (flow-mediated vasodilation,
myogenic reactivity, arterial compliance), and 2. Pharmacological
stimuli, which can be subdivided by: a. The agent used (including
acetylcholine, norepinephrine, phenylephrine, etc.) or b. The
mediating receptor complex involved [8]. Most studies have
concentrated on agents that affect the G-protein coupled
receptors. These can be divided into three common G-protein
coupled receptor pathways: the vasodilator GqEC-pathway which
mediates NO-dependent vasodilation, the vasoconstrictor GqSMC-
pathway which induces a calcium rise in the SMC, and the
vasodilator GsSMC-pathway which induces potassium influx in the
SMC [8–15].
Various species, strains and gestational age periods have been
investigated and often the results have been extrapolated to
pregnancy-induced renal adaptation in general and to responsible
mechanisms in humans. One may question the validity of such
extrapolations. A previous meta-analysis showed that in mesen-
teric arteries vascular adaptation to pregnancy is strongly
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dependent on species, strains and gestational ages [8]. This may
also be the case for renal arteries.
To investigate which mechanisms are responsible for renal
vascular changes in pregnancy and whether they are dependent on
species, strains and gestational age periods, we performed a
systematic review and meta-analysis on the functional vascular
changes of the kidney during pregnancy. Questions to be answered
included: 1. Which specific renal vasodilator pathways are
activated in pregnancy and to what extent do they affect RVR,
renal flow and GFR across species, strains and gestational ages, 2.
Are the pregnancy-induced changes in RVR, renal flow and GFR
dependent on renal artery adaptation and which specific
vasodilator pathways affect the renal artery during pregnancy,
and 3. At which cellular level does pregnancy affect the involved
pathways?
Materials and Methods
Retrieving the literature
In an attempt to identify all original studies on renal vasoactive
responses in animals and humans during first pregnancy, we
searched the Pubmed (from 1948) and Embase (from 1980)
databases until April 2012. We used a three phase search strategy.
Tables 1 and 2 depict the search-strategy for Pubmed and
Embase, respectively. No language restriction was used in the
primary literature search; later in the process non-English studies
were excluded. We also searched the reference lists of included
studies to identify additional studies. The search strategy was
developed in cooperation with an information specialist from the
Medical Library of the Radboud University Nijmegen.
Selection of studies and data extraction
The selection and data extraction process was divided into three
phases. In the first phase, a. one investigator (first author) selected
studies on the basis of title and abstract, and b. two investigators
(first and second author) independently screened all remaining
abstracts for inclusion criteria. Differences were resolved by
mutual agreement. Studies were selected if they met the following
criteria: 1. renal vasoconstrictor/vasodilator responses, 2. first
pregnancy versus nulliparous non-pregnant control, 3. original
data, 4.) healthy animals or humans, 5. age- or weight-matched
subjects, and 6. for ex-vivo experiments: experiments performed in
standard medium (defined as a generally accepted medium for the
type of experiments). In the second phase of selection, non-English
papers were excluded from further analysis and full articles were
analyzed by two investigators (first and second author) indepen-
dently using the same inclusion criteria as described above.
Differences were resolved by mutual agreement. In the third
phase, the first author extracted baseline measurements and
responses to specific blockade from in vivo and whole organ
perfusion experiments that related to renal function changes and
the involved pathways. In addition, all vasodilator and vasocon-
strictor responses were extracted both in the absence and presence
of blockade of NO, prostaglandin (PGI2), renin-angiotensin-
aldosterone (RAAS), endothelin, vasopressin or the sympathetic
system, or combinations of blockade, with and without denuded
endothelium. Responses had to contain $5 measurements to be
included in further analysis, as analysis of sensitivity to stimuli is
not accurate with fewer data points.
From each article, study data were extracted and recorded for
species, strain, and gestational age (early, mid and late pregnancy,
defined as first, second and third trimester, respectively), estrous/
cycle stage, and experimental setup (in vivo/whole organ
perfusion, myograph type used). We extracted all reported
vascular responses and recorded for each of them the number of
subjects, effect size, and standard deviation or standard error of
the mean. For in vivo and whole organ perfusion experiments we
detected baseline renal vascular resistance (RVR), renal flow
(combined renal plasma, blood and perfusion flow), glomerular
filtration rate (GFR), autoregulatory threshold (lower pressure
limit for stable renal flow), and the response to specific blockades.
For pharmacological responses, we extracted EC50 (concentration
inducing 50% of the maximum effect) and Emax (maximum
response to stimulus) to indicate sensitivity and maximum
reactivity, respectively. For the mechanical responses, we deter-
mined the direction of the effect (favoring vasodilation, vasocon-
striction, or no effect) and used it for descriptive analysis.
Parametric comparison of these responses was not possible, as
Table 1. Literature search-strategy for Pubmed.
Component Description
Pregnancy ‘‘pregnancy’’ [MeSH Terms] OR ‘‘pregnancy’’ [tiab] OR ‘‘pregnancies’’ [tiab] OR ‘‘gestation’’ [tiab] OR ‘‘pregnant’’ [tiab] OR ‘‘maternal-fetal
relations’’ [tiab]
Renal circulation ‘‘renal artery’’ [MeSH] OR ‘‘renal artery’’ [tiab] OR ‘‘renal arteries’’ [tiab] OR ‘‘kidney artery’’ [tiab] OR ‘‘kidney arteries’’ [tiab] OR ‘‘renal
blood vessel’’ [tiab] OR ‘‘renal blood vessels’’ [tiab] OR ‘‘kidney blood vessel’’ [tiab] OR ‘‘kidney blood vessels’’ [tiab] OR ‘‘renal vessel’’
[tiab] OR ‘‘renal vessels’’ [tiab] OR ‘‘kidney vessel’’ [tiab] OR ‘‘kidney vessels’’ [tiab] OR ‘‘arteria renalis’’ [tiab] OR ‘‘arteria renis’’ [tiab] OR
‘‘kidney/blood supply’’ [MeSH] OR ‘‘renal circulation’’ [MeSH] OR ‘‘renal circulation’’ [tiab] OR ‘‘kidney circulation’’ [tiab] OR ‘‘renal blood
circulation’’ [tiab] OR ‘‘kidney blood circulation’’ [tiab] OR ‘‘renal blood supply’’ [tiab] OR ‘‘kidney blood supply’’ [tiab]
Vasoconstrictor and vasodilator
responses
‘‘vasoconstriction’’ [MeSH Terms] OR ‘‘vasoconstriction’’ [tiab] OR ‘‘vasoconstrictions’’ [tiab] OR ‘‘vasoconstrictor agents’’ [MeSH Terms]
OR ‘‘vasoconstrictor agents’’ [Pharmacological Action] OR ‘‘vascular resistance’’ [MeSH Terms] OR ‘‘vascular resistance’’ [tiab] OR
‘‘vascular capacitance’’ [MeSH Terms] OR (‘‘vascular’’ [tiab] AND ‘‘capacitance’’ [tiab]) OR ‘‘vasoconstrictor’’ [tiab] OR ‘‘vasoconstrictors’’
[tiab] OR ‘‘vasopressor’’ [tiab] OR ‘‘vasoactive agonist’’ [tiab] OR ‘‘vasoactive agonists’’ [tiab] OR ‘‘vasopressors’’ [tiab] OR ‘‘vasomotor
system’’ [MeSH Terms] OR ‘‘vasomotor system’’ [tiab] OR ‘‘peripheral resistance’’ [tiab] OR ‘‘artery constriction’’ [tiab] OR ‘‘vessel
constriction’’ [tiab] OR ‘‘vasoconstrictive’’ [tiab] OR ‘‘vasoconstricting’’ [tiab] OR ‘‘vasoconstricted’’ [tiab] OR ‘‘vasodilation’’ [MeSH Terms]
OR ‘‘vasodilation’’ [tiab] OR ‘‘vasodilatation’’ [tiab] OR ‘‘vasodilatating’’ [tiab] OR ‘‘vasodilating’’ [tiab] OR ‘‘vasodilative’’ [tiab] OR
‘‘vasodilatative’’ [tiab] OR ‘‘artery dilation’’ [tiab] OR ‘‘vessel dilation’’ [tiab] OR ‘‘artery dilatation’’ [tiab] OR ‘‘vessel dilatation’’ [tiab] OR
‘‘vasodilator agents’’ [MeSH Terms] OR ‘‘vasodilator agents’’ [Pharmacological Action] OR ‘‘vasodilator’’ [tiab] OR ‘‘vasodilators’’ [tiab]
OR ‘‘vasorelaxation’’ [tiab] OR ‘‘Vascular Endothelium Dependent Relaxation’’ [tiab] OR ‘‘Endothelium Dependent Relaxation’’ [tiab] OR
‘‘Vascular Endothelium-Dependent Relaxation’’ [tiab] OR ‘‘Endothelium-Dependent-Relaxation’’ [tiab] OR ‘‘hemodynamics’’ [MeSH
Terms] OR ‘‘hemodynamics’’ [tiab]OR ‘‘hemodynamic’’ [tiab] OR ‘‘vasodilated’’ [tiab] OR ‘‘vasoactive agent’’ [tiab] OR ‘‘vasoactive drug’’
[tiab] OR ‘‘vasoactive drugs’’ [tiab] OR ‘‘dilation’’ [tiab] OR ‘‘dilatation’’ [tiab] OR ‘‘contraction’’ [tiab] OR ‘‘relaxation’’ [tiab]
doi:10.1371/journal.pone.0112084.t001
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analyses (mostly ANOVA statistics) did not allow calculating
overall effect sizes and effect measures were reported in variable
ways (for myogenic reactivity and arterial compliance (absolute
values, percentages of diameter changes, myogenic tone in relation
to passive tone)). In case of missing, incomplete or indeterminate
data, we approached the authors by email (response rate 33%).
Quality assessment
The methodological quality of the articles was assessed
independently by two reviewers (first and second author). Data
were scored on presence or absence of randomization of allocation
to groups, blinding of outcome assessment, clearness on nulliparity
at entry of study, age or weight of subjects described, and number
of animals accounted for at the start and the end of the study. The
quality of the responses reported was ranked for the clarity of the
number of animals used for analyses, presence of a response graph
containing $5 measurements, and achievement of Emax (defined
as the presence of at least two measurements without any further
increasing effect). The response quality was expressed as percent-
age of the number of responses that complied with these items
divided by the total number of responses described in the study. It
should be noted that the quality assessment determines the quality
of the methodology required for comparison of responses to the
predefined items and that it should not be interpreted as judgment
of the value of the experiment per se.
Quantitative data synthesis and statistical analysis
Extracted data in RVR, renal flow and GFR at baseline,
changes induced by specific blockades, and EC50 and Emax for
pharmacological stimuli were analyzed for each gestational age
period, stratified by species and strain, and displayed in forest
plots, using Review Manager 5 (The Nordic Cochrane Centre,
The Cochrane Collaboration, 2008). Pharmacological stimuli
were analyzed by the type of G-protein-coupled pathway
(GqEC,GqSMC and GsSMC) involved or by type of stimulus (NO-
donors and potassium), when applicable. Combined effect sizes
were calculated as weighed mean difference (MD) for RVR, renal
flow, GFR and EC50, and as standardized mean difference (SMD)
for Emax. Both MD and SMD represent the effect sizes in
comparison to control values within the same study. In the forest
plots data were presented as mean effect sizes with 95%
confidence intervals (CI), as provided by Review Manager 5.
Combined effect sizes were calculated by using the random effects
model (Review Manager 5). In the forest plots, the size of the
boxes represents the weight of the studies, the gray diamonds
depict the overall effect size per species and strain, and the black
diamonds illustrate the overall effect sizes. We used a significance
level of alpha = 0.05 to identify statistically significant results. In
the random effects model some heterogeneity beyond sampling
errors is allowed to account for anticipated heterogeneity.
Heterogeneity was presented as I2; I2,60% represents moderate
heterogeneity, I2.60% represents considerable to substantial
heterogeneity [16]. Publication bias was assessed by linear
regression analysis as proposed by Egger et al. (for $10 studies)
[17] or subjective assessment of funnel plot asymmetry (for #10
studies).
For mechanical stimuli, we used the direction of the measured
effects for qualitative analysis, and determined the overall weighed
direction for each mechanical response, based on the total number
of animals used.
We performed sensitivity analysis to assess the robustness of our
findings, as is recommended for systematic reviews [16]. This type
of analysis shows the influence of the used inclusion and exclusion
criteria on the results. In the analysis we repeated all analyses in
the presence of the studies that were excluded on the basis of the
criterion first pregnancy versus nulliparous non-pregnant control.
References used for analysis included the following: [18–54].
Results
Our systematic literature search identified 1008 studies
concerning the effects of pregnancy on vascular changes of the
kidney (Figure 1). Based on title and abstract 917 studies were
excluded, leaving 91 papers for full article evaluation. Thirty-seven
studies did not meet the inclusion criteria. Seventeen studies were
excluded based on their non-English language. Finally, 37 studies
with 116 vascular responses met the inclusion criteria for meta-
analysis.
Table 2. Literature search-strategy for Embase.
Component Description
Pregnancy exp pregnancy/OR (pregnancy or pregnant).ti,ab. OR (pregnacies or gestation).ti,ab. OR (pregnancy or pregnant or pregnacies or
gestation).ti,ab.
Renal circulation exp renal artery/OR renal artery.ti,ab. OR renal arteries.ti,ab. OR arteria renalis.ti,ab. OR exp kidney artery/OR kidney artery.ti,ab. OR
kidney arteries.ti,ab. OR arteria renis.ti,ab. OR kidney blood vessel/OR renal blood vessel.ti,ab. OR renal blood vessels.ti,ab. OR kidney
blood vessel.ti,ab. OR kidney blood vessels.ti,ab. OR intrarenal vessel.ti,ab. OR intrarenal vessels.ti,ab. OR renal vessel.ti,ab. OR renal
vessels.ti,ab. OR kidney vessel.ti,ab. OR kidney vessels.ti,ab. OR exp kidney blood flow/OR kidney blood flow.ti,ab. OR intrarenal blood
flow.ti,ab. OR kidney bloodflow.ti,ab. OR renal blood flow.ti,ab. OR kidney blood supply.ti,ab. OR renal blood supply.ti,ab. OR exp kidney
circulation/OR kidney circulation.ti,ab. OR intrarenal circulation.ti,ab. OR kidney blood circulation.ti,ab. OR renal circulation.ti,ab. OR
renal blood circulation.ti,ab.
Vasoconstrictor and vasodilator
responses
exp vasoconstriction/OR exp vasoconstrictor agent/OR vasoconstrict*.ti,ab. OR exp vascular resistance/OR blood flow resistance.ti,ab.
OR blood vessel resistance.ti,ab. OR (peripheral adj1 resistance).ti,ab. OR vascular vessel resistance.ti,ab. OR artery resistance.ti,ab. OR
exp hemodynamics/OR exp blood vessel capacitance/OR blood vessel capacitance.ti,ab. OR vascular capacitance.ti,ab. OR
(hemodynamic or hemodynamics).ti,ab. OR (haemodynamic or haemodynamics).ti,ab. OR vasopressor.ti,ab. OR exp vasoactive agent/
OR (vasoactive agonist OR vasoactive agonists or vasoactive agent or vasoactive agents or vasoactive drug or vasoactive drugs).ti,ab.
OR (vessel contriction or vessel contrictions or artery contriction or artery constrictions).ti,ab. OR exp vasodilatation/OR (vasodilatation
or vasodilation or vasodilator or vasodilatator or vasodilating or vasodilative or vasodilatative).ti,ab. OR (vaso dilatation or vaso
dilation or vaso dilator or vaso dilatator or vaso dilating or vaso dilative or vaso dilatative).ti,ab. OR vaso relaxation.ti,ab. OR vascular
endothelium dependent relaxation.ti,ab. OR vascular endothelium-dependent relaxation.ti,ab. OR endothelium dependent
relaxation.ti,ab. OR endothelium-dependent relaxation.ti,ab. OR (vessel dilatation* or vessel dilation* or vascular dilation* or vascular
dilatation* or vasorelaxation* or artery dilatation* or artery dilation*).ti,ab. OR (dilatation* or dilation* or relaxation* or
contraction*).ti,ab.
doi:10.1371/journal.pone.0112084.t002
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The study characteristics are presented in Table 3. Most studies
(n = 28) used rats (Long Evans rats (LER), Sprague Dawley rats
(SDR), various strains of Wistar rats (Wistar Kyoto (WKR),
Munich Wistar (MWR) and Wistar Hannover (WHR)); other
species were used less frequently (sheep = 6, rabbits = 2 and
guinea pigs (GP) = 1). Most studies contained in vivo experiments
Figure 1. Flow chart for selection, inclusion and exclusion of studies and responses on renal vascular adaptation to pregnancy. n=
number of studies; r = number of responses (gray filling for in vivo and whole organ perfusion experiments, dotted filling for renal artery responses).
doi:10.1371/journal.pone.0112084.g001
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(n = 25), while whole organ (perfusion), perfusion myograph and
wire myograph experiments were less common (n= 5, 3 and 4
respectively). Methodological limitations were present in a
substantial portion of the included studies (Table 4): 43% (16/
37) did not present the number of animals used, 32% (12/37) did
not present parity, 97% (36/37) did not report having performed
randomization, and 0% reported blinding of the outcome
assessment.
The 116 subtracted vascular responses could be divided into
two categories: 1. in vivo and whole organ perfusion studies
measuring changes in RVR, renal flow and/or GFR, and 2. renal
artery experiments measuring changes in vascular tone. Experi-
ments were performed mainly in mid (34%, 40/116) and late
(63%, 73/116) gestation; for four responses the gestation period
was not defined. Early gestation was not investigated by any of the
included studies.
Table 3. Characteristics of included studies, arranged by author and year.
Study
Species
(strain)
Estrous stage
control group
Gestation
period
Experiment
setup
Number of described
baseline measurements
Number of
described responses
Annibale et al., 1989 sheep - late WM n.a. 4
Baylis et al., 1986 rat (MWR) - late IV 4 10
Baylis et al., 1988 rat (MWR) - mid IV 3 0
Baylis et al., 1993 rat (SDR and
MWR)
- mid/late IV 4 4
Baylis et al., 1995 rat (SDR)# - mid/late IV 2 2
Bobadilla et al., 2001 rat (WR) - ? WOP 1 4
Bobadilla et al., 2003 rat (WR) - mid/late WOP 2 16
Bobadilla et al., 2005 rat (WR) - late WOP 1 2
Cha et al., 1993 sheep - late IV 1 0
Cha et al., 1993 sheep - late IV 1 0
Chu et al., 1997 rat (WKY) - late WOP 0 0
Conrad et al., 1989 rat (LE) - late IV 1 1
Conrad et al., 1999 rat (LE) - mid IV 1 2
Danielson et al., 1995 rat (LE) - mid IV 1 3
Danielson et al., 1996 rat (LE) - mid IV 1 2
Fan et al., 1996 sheep - late IV 1 0
Ferris et al., 1983 rabbit - late IV 2 0
Gandley et al., 1997 rat (SDR) - late PM n.a. 4
Gandley et al., 2001 rat (LE) - mid PM n.a. 9
Greenberg et al., 1999 sheep - late IV 1 0
Griggs et al., 1993 rat (SDR) - late PM n.a. 6
Hines et al., 1992 rat (SDR) - mid/late IV 2 4
Hines et al., 2000 rat (SDR) - late IV 1 1
Kim et al., 1994 guinea pig - Late WM n.a. 12
Knight et al., 2007 rat (SDR) - late IV 0 0
Masilamani et al., 1994 rat (SDR) - mid/late IV 1 0
McElvy et al., 2001 sheep - late IV 1 0
Novak et al., 1997 rat (SDR) - mid IV 1 0
Omer et al., 1999 rat (SDR) - late IV 1 1
Patel et al., 1993 rat (SDR) - late IV 2 0
Reckelhoff et al., 1992 rat (WR) - mid IV 2 2
Sen et al., 1997 rat (?) - mid/late IV 2 0
Sicinska et al., 1971 rat (SDR) - late IV 1 0
Van Drongelen et al., 2011 rat (WR) - mid WOP 1 1
Van Eijndhoven et al., 2003 rat (WR) - mid WM n.a. 1
Van Eijndhoven et al., 2007 rat (?) - mid WM n.a. 2
Woods et al., 1987 rabbit - late IV 1 1
WM = wire myograph, PM = pressure myograph, PPM = pressure-perfusion myograph, WOP = whole organ perfusion, IV = in vivo. n.a. = not applicable.
#data received by email.
doi:10.1371/journal.pone.0112084.t003
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We identified 78 in vivo and whole organ perfusion exper-
iments. Two types of experiments could be distinguished based on
their objective to determine the effects of pregnancy on: 1) RVR,
renal flow and GFR, or 2) the response of the kidney to vaso-active
substances. For the first type of experiments we extracted 42
baseline measurements and 20 responses to specific blockades.
Thirty-six responses were excluded as they did not measure RVR,
renal flow or GFR. After exclusion of incomplete data, 27 baseline
measurements and 11 responses to specific blockades were suitable
for meta-analysis. For the second type of experiments we identified
23 pharmacological and 3 mechanical responses. For pharmaco-
logical stimuli, EC50 was reported in 0% of the responses, Emax
was described in 9% and a graph was present in 91%. For
mechanical stimuli, all responses were presented graphically
without quantified effects.
From the 38 renal artery responses, 28 met the criteria for
inclusion. They consisted of 22 pharmacological stimuli (EC50,
Emax and a graph present in 100%, 32% and 95% of the cases,
respectively) and six mechanical stimuli, all with a graph without
quantified effects.
In vivo and whole organ perfusion experiments
The influence of mid pregnancy on kidney function is presented
in Figure 2. In mid pregnancy, overall (across species and strains)
RVR decreases by 27%, varying from 18% in SDR to 31% in
MWR. Renal flow is enhanced to a variable degree, ranging from
13% in WHR to 31% in LER. GFR increases by 17% in SDR to
29% in LER. In LER, blockade of the NO system completely
normalizes the pregnancy-induced change in RVR and GFR,
while pregnancy-induced increase in renal flow is reduced from
31% to 15%. In WR, NO-blockade normalizes renal flow
completely. Sympathetic or vasopressin blockade has only been
studied in SDR and does not affect the mid pregnancy-induced
changes in RVR, renal flow and GFR. It appears that mid
pregnancy changes in RVR, renal flow and GFR are dependent
on up regulation of the NO system and not on sympathetic tone or
vasopressin.
The magnitude of pregnancy-induced renal changes in rats
decreases from mid pregnancy towards term. Figures 3 and 4
show renal function in late gestation compared to non-pregnant
controls. Late pregnancy affects RVR, renal flow and GFR
differently among species and strains. In LER and MWR,
pregnancy does not affect any of the renal parameters. Blockade
of the renin-angiotensin-aldosteron system (RAAS) did not show
any effect in LER, but in MWR reduced RVR by 26% and
increased renal flow by 26% without changing in GFR. In SDR,
pregnancy decreases RVR by 19% and increases both renal flow
and GFR, by 17% and 21% respectively. NO blockade in this
strain returns renal flow to non-pregnant values with a persistently
increased GFR. Under sympathetic blockade RVR, renal flow and
GFR return to non-pregnant values in these rats, while vasopressin
blockade has no effect on any of the parameters. In rabbits, late
pregnancy does not significantly affect RVR, while renal flow and
GFR are increased by 29% and 39% compared to non-pregnant
values. These changes are not affected by RAAS-blockade. For
late pregnant sheep, no data are available on RVR, but renal flow
is 21% higher than in non-pregnant sheep without a significant
difference in GFR. In short, there is no consistent pattern of renal
changes in late pregnancy across species and strains.
In both mid and late pregnancy, the overall RVR, renal flow
and GFR shows moderate to considerable heterogeneity. This
cannot be attributed completely to species or strain specific effects,
as stratification by species and/or strain does not reduce
heterogeneity to a minimum in all groups. Heterogeneity depends
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mainly on single responses with very small confidence intervals
and responses with an estimated effect opposite to other studies.
We could not identify any methodological issue that might explain
these effects.
The influence of pregnancy on the autoregulatory threshold was
analyzed qualitatively only, as quantitative effect measures of the
lower pressure boundary for stable renal flow were not reported in
the two relevant studies, which used WR and rabbits [21,54].
From these studies it appears that pregnancy does not affect the
renal autoregulatory threshold in either mid or late pregnancy.
Figure 2. Effect of pregnancy at mid gestation on in vivo and whole organ perfusion# renal vascular resistance (RVR), renal flow
and glomerular filtration rate (GFR) in absence and presence of NO and sympathetic blockade. The effect of pregnancy on RVR, renal
flow (effects of renal plasma/blood/perfusion flow (RPF/RBF/RPPF) combined) and GFR is presented as percentage mean difference (MD) and its 95%
CI. Studies and totals based on Long Evans rats (LER), Munich Wistar rats (MWR), Sprague Dawley rats (SDR) and Wistar Hannover rats (WHR). 1, 2, 3
represents first, second and third part of mid gestation. # Whole organ perfusion experiments, excluded in the ‘‘Overall in vivo‘‘ analysis. *
Experiments performed under anesthesia. I2 represents the amount of heterogeneity. n.a. = not applicable.
doi:10.1371/journal.pone.0112084.g002
Figure 3. Effect of pregnancy at late gestation on in vivo renal vascular resistance (RVR), renal flow and glomerular filtration rate
(GFR) in absence of blockade. The effect of pregnancy on RVR, renal flow (effects of renal plasma/blood/perfusion flow (RPF/RBF/RPPF)
combined) and GFR is presented as percentage mean difference (MD) and its 95% CI. Studies and totals based on Long Evans rats (LER), Munich
Wistar rats (MWR), Sprague Dawley rats (SDR), rabbits and sheep. 1, 2, 3 represents first, second and third part of late gestation. * Experiments
performed under anesthesia. I2 represents the amount of heterogeneity. n.a. = not applicable.
doi:10.1371/journal.pone.0112084.g003
Renal Vascular Changes during Pregnancy
PLOS ONE | www.plosone.org 8 November 2014 | Volume 9 | Issue 11 | e112084
Renal artery experiments
The renal artery changes in response to vasodilator GqEC-
coupled pharmacological stimuli in pregnancy are presented in
Figure 5. Our search only detected responses during late gestation,
and mainly in guinea pigs. In this species, pregnancy does not
affect GqEC-coupled EC50 to acetylcholine and EC50 is unaffected
by NO and PGI2 blockade.
The effects of mid and late pregnancy on the vasoconstrictor
GqSMC-coupled pathway in several species are shown in Figure 6;
no data are available on early gestation. In both mid and late
gestation, the GqSMC-coupled EC50 and Emax of phenylephrine
and U46619 (thromboxane agonist) are unaffected by pregnancy
for all species investigated. In guinea pigs under NO and PGI2
blockade, pregnancy does not affect the response to U46619. In
SDR in the absence of endothelium pregnancy increases EC50 in
response to phenylephrine, which suggests that the pregnancy
effect on the SMC is overruled by the endothelium. Apparently,
pregnancy does not seem to affect the renal artery responsiveness
to GqSMC-coupled vasoconstrictor stimuli.
The effect of pregnancy on the renal artery responses to NO
and potassium are depicted in Figure 7. For NO, only single
studies in rats and sheep were available. In mid and late gestation
rats and late pregnant sheep pregnancy does not modify the
response to NO or potassium. This suggests that in general
pregnancy does not affect the properties of the renal SMC to NO
and potassium.
The effect of pregnancy on the renal artery responses to
mechanical stimuli was assessed qualitatively only, as shown in
Figure 8. We did not find studies that investigated flow-mediated
vasodilation of the renal artery during pregnancy, and only two
studies that looked at myogenic reactivity and vascular compliance
in late gestation. In SDR, late pregnancy reduces myogenic
reactivity in an endothelium-dependent manner and enhances
vascular compliance. In sheep, late pregnancy does not affect
either myogenic reactivity or vascular compliance. Apparently,
pregnancy-induced changes in myogenic reactivity and compli-
ance depend on the species investigated.
Publication bias and sensitivity-analysis
Publication bias was assessed by subjective determination of
funnel plot asymmetry, as all analyses consisted of less than 10
studies. We did not detect evidence suggestive for publication bias.
Sensitivity-analysis was performed to assess the influence of
inclusion criteria on the results. We extended the inclusion for
studies that did not match the criterium ‘‘nulliparity’’ (n = 3). The
results were not affected by addition of these studies (data not
shown). We did not extend the analysis for age-matching, because
we had not excluded any study for that reason.
Discussion
Our meta-analysis confirms the commonly held view that
pregnancy reduces RVR and enhances renal flow and GFR in
animals, as it does in humans [1]. Our study has shown that the
degree of change depends on the functional parameter, species,
strain and gestational age investigated. Our meta-analysis did not
detect changes in renal artery responsiveness. More importantly,
the underlying mechanisms for the change in RVR, renal flow and
GFR is not the same between species, strains and gestational age.
Therefore each research question needs careful choice of the
animal model and gestational age period of interest.
Across rat strains at mid-gestation, pregnancy decreases RVR
and enhances renal flow and GFR, as shown in Figure 2. The
effect of pregnancy on RVR and GFR is quite consistent, whereas
Figure 4. Effect of pregnancy at late gestation on in vivo renal vascular resistance (RVR), renal flow and glomerular filtration rate
(GFR) in presence of NO, sympathetic and RAAS blockade. The effect of pregnancy on RVR, renal flow (effects of renal plasma/blood/
perfusion flow (RPF/RBF/RPPF) combined) and GFR is presented as percentage mean difference (MD) and its 95% CI. Studies and totals based on
Long Evans rats (LER), Munich Wistar rats (MWR), Sprague Dawley rats (SDR) and rabbits. 1, 2, 3 represents first, second and third part of late
gestation. * Experiments performed under anesthesia. I2 represents the amount of heterogeneity. n.a. = not applicable.
doi:10.1371/journal.pone.0112084.g004
Renal Vascular Changes during Pregnancy
PLOS ONE | www.plosone.org 9 November 2014 | Volume 9 | Issue 11 | e112084
there is considerable variation in renal flow. This may suggest
differences in renal blood pressure between strains. We observed
that the common changes in RVR, renal flow and GFR are caused
by NO upregulation rather than by change in renal autoregulatory
threshold to pressure, or sympathetic or vasopressin-regulation.
At late gestation, the pregnancy effects on RVR, renal flow and
GFR are dependent on the species and strain investigated
(Figure 3). In some species or strains, renal parameters are not
different from non-pregnant values (LER and MWR), while in
others late pregnancy affects RVR, renal flow and GFR (SDR,
rabbits and sheep). The renal autoregulatory threshold to pressure
changes was not affected in any species investigated. The NO,
RAAS, sympathetic and vasopressin pathways are differently
affected across species and strains. In SDR, NO activation affects
renal flow, but not GFR. This implies a difference in response to
NO activation between the afferent and efferent glomerular
vasculature.
The pregnancy-induced reduction in RVR and the associated
increase in renal flow and GFR across the species studied are
dependent on gestational age, as shown in Figures 2 and 3. Our
analysis includes data on both mid- and late gestation in LER,
MWR and SDR (Figure 9). In LER and MWR, all measured
renal changes are maximal in mid-gestation and return towards
non-pregnant levels in late gestation, whereas in SDR there is no
difference between mid- and late pregnancy response. Responses
in LER and MWR qualitatively correspond well with human
pregnancy, in which renal flow increases in the first and second
trimesters and decreases markedly towards term [1]. Quantita-
tively, in human pregnancy the renal flow increase (around 60%) is
more pronounced than in the rat strains included in our meta-
analysis (LER 31%, MWR 45% and SDR 14%). One may
speculate on the underlying mechanism for this difference.
Possibly the more mature human fetus poses a greater demand
on the maternal vascular system, than the more immature rat fetus
at comparable gestational age period. Our data suggest that renal
changes during pregnancy in humans and rats are qualitatively
similar but quantitatively different.
It is questionable if SDR is the right model for renal changes in
healthy human pregnancy. In contrast to humans in which RVR,
renal flow and GFR return towards non-pregnant values near
Figure 5. Effect of pregnancy at late gestation on renal artery responses to stimuli involved in vasodilation through the GqEC-
coupled pathway in the presence and absence of blockade. The effect of pregnancy on EC50 (the dose of stimulus inducing 50% response) is
depicted as mean difference (MD) and its 95% confidence interval (95% CI). Emax (maximum response) is presented as standardized mean difference
(SMD) and its 95% CI. Studies and totals based on Sprague Dawley rats (SDR) and guinea pigs (GP). 1, 2, 3 represents first, second and third part of late
gestation. I2 represents the amount of heterogeneity. n.a. = not applicable.
doi:10.1371/journal.pone.0112084.g005
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term, the changes in SDR are maximal in mid-pregnancy and
remain at maximum level throughout late pregnancy. As shown in
Figure 9, this pattern is different from that in the other rat strains
investigated (LER, MWR), that matches better with the human
pattern. The persistent changes in SDR may reflect their relatively
compromised vascular health. This strain is known to develop
severe vascular dysfunction later in life, including chronic
progressive nephropathy, peri-/vasculitis, and chronic cardiomy-
opathy [55]. SDR could be the better model for renal vascular
maladaptation, whereas LER and MWR seem the more
appropriate models for normal pregnancy-induced renal vasodi-
lation.
Our meta-analysis detected considerable heterogeneity (I2.
60%) for overall renal flow and moderate heterogeneity (I2,60%)
for overall GFR and RVR. This can only partially be attributed to
differences between species and strains, as stratification reduced
heterogeneity substantially only for some subgroups. Additionally,
methodological differences in determining renal flow (flow probe
or para-aminohippurate clearance) may have contributed to the
heterogeneity. The substantial degree of heterogeneity implies that
data should not be quantitatively extrapolated to other species or
strains.
Renal artery function is not affected by pregnancy, except for
SDR. Pregnancy does not change the renal artery responsiveness
to pharmacological stimuli (GqEC- and GqSMC-mediated stimuli,
NO and potassium). One study in SDR showed an endothelium-
dependent decrease in renal artery myogenic reactivity and
increased vascular compliance in late pregnancy. Apparently
SDR activate additional mechanisms to realize the same degree of
vascular adaptation to pregnancy, as compared to other strains.
This may represent a more generalized pattern, as it has been
reported that SDR activate additional vascular adaptive pathways
also in mesenteric arteries responses in pregnancy [8].
One may question what mechanisms are responsible for the
changes in RVR, renal flow and GFR in pregnancy, given the lack
of a role for renal artery adaptation. Our meta-analysis does not
Figure 6. Effect of pregnancy at mid and late gestation on renal artery responses to stimuli involved in vasoconstriction through
the GqSMC-coupled pathway in presence and absence of blockade. The effect of pregnancy on EC50 (the dose of stimulus inducing 50%
response) is depicted as mean difference (MD) and its 95% confidence interval (95% CI). Emax (maximum response) is presented as standardized mean
difference (SMD) and its 95% CI. Studies and totals based on Long Evans rats (LER), Sprague Dawley rats (SDR), sheep and guinea pigs (GP). 1, 2, 3
represents first, second and third part of mid and late gestation. I2 represents the amount of heterogeneity. n.a. = not applicable.
doi:10.1371/journal.pone.0112084.g006
Figure 7. Effect of mid and late pregnancy on renal artery responses to nitric oxide (NO) and potassium. The effect of pregnancy on
EC50 (the dose of stimulus inducing 50% response) is depicted as mean difference (MD) and its 95% confidence interval (95% CI). Emax (maximum
response) is presented as standardized mean difference (SMD) and its 95% CI. Studies and totals based on Long Evans rats (LER), Sprague Dawley rats
(SDR) and sheep. 1, 2, 3 represents first, second and third part of mid and late gestation. I2 represents the amount of heterogeneity. n.a. = not
applicable.
doi:10.1371/journal.pone.0112084.g007
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provide the answer. Several mechanisms can be considered.
Reduced RVR and enhanced renal flow and GFR in pregnancy
most likely result from regulation by the small resistance vessels of
the kidney, rather than the renal artery [56]. The juxtaglomerular
apparatus, which regulates afferent and efferent glomerular artery
tone, may also be involved through resetting of the tubuloglo-
merular feedback system [57]. It seems likely that pregnancy-
specific hormones, including relaxin or progesterone, play a role in
these processes [58,59].
Several methodological aspects of our meta-analysis deserve
discussion. First, the quality of all included studies was scored as
poor, in terms of the reported number of animals, parity,
randomization, and blinding the outcome assessment. This is a
common finding in animal experiments [8], which are primarily
concerned with generation and testing of hypotheses rather than
with rigorous employment of randomized-controlled-trial meth-
odology. Nonetheless, the quality of animal experimental work,
and therefore the reliability of its findings, could benefit from
application of strict methodological criteria, standardized proce-
dures and reporting guidelines [60]. Second, our literature search
was not designed to identify all studies that reported on pregnancy-
induced changes in RVR, renal flow and GFR. Because we were
primarily interested in the underlying mechanisms, we restricted
our search to studies investigating responses to vaso-active stimuli.
Many studies in different animals have investigated RVR, RPF
and GFR without using vaso-active stimuli. These studies were not
included in our meta-analysis. Our data on pregnancy-induced
changes imply species, strain and gestational age differences in
RVR, RPF and GFR, without having the intention to be complete
on this. Third, despite extensive searches, some of our observations
are still based on a limited number of animals and strains of
animals. Obviously, these results have to be interpreted with some
restraint. Fourth, publication bias may have affected the results.
Negative results tend to be underreported, which may therefore
lead to overestimated effect sizes. Our funnel-plot analysis did not
detect any such effect. Fifth, one may question whether it is
legitimate to group together responses to pharmacological stimuli
across species and strains. We observed considerable heterogeneity
(I2.60%), which implies that one should not regard the responses
as uniform across species and strains. Sixth, one may question the
validity of combining the responses to different stimuli according
to their assumed common G-protein coupled pathway. If
heterogeneity would have been low, it would have been reasonable
to group together the various stimuli to their common pathways,
as observed in a former study of our group [61]. The moderate
heterogeneity, observed for most responses in the present study,
might imply that the assumption is not valid. However, it does not
necessarily disprove the validity, because heterogeneity may be
affected by many methodological aspects of the experiments.
Given the moderate heterogeneity, one should mainly focus on the
qualitative similarities.
In conclusion, our meta-analysis shows that pregnancy reduces
RVR and increases renal flow and GFR through NO activation
and sympathetic de-activation and not through a change in renal
artery responsiveness. The cellular level at which pregnancy affects
the respective pathways remains unknown. Quantitatively, renal
vascular changes in pregnancy vary between species, strains and
gestational age. Our meta-analysis suggests that renal changes
during pregnancy are qualitatively similar in animals and even in
comparison to humans, but quantitatively different.
Figure 8. Effect of pregnancy at late gestation on renal artery responses to myogenic response and vascular compliance. The effect
of pregnancy on the response to stimuli, depicted as the difference in direction.? = unknown or non-conclusive data. Studies and totals based on
Sprague Dawley rats (SDR) and sheep. 1, 2, 3 represents first, second and third part of late gestation. n = number of subjects.
doi:10.1371/journal.pone.0112084.g008
Figure 9. Summary of renal vascular resistance (RVR), renal
flow and glomerular filtration rate (GFR) during pregnancy in
Long Evens rats (LER), Munich Wistar rats (MWR) and Sprague
Dawley rats (SDR). Graph design based on data at mid- and late
gestation. No data were available on early pregnancy.
doi:10.1371/journal.pone.0112084.g009
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